CellSource Shares Drop 7% After Cutting Fiscal 2024 Financial Forecasts

MT Newswires Live

2024/09/13

CellSource (TYO:4880) has cut its financial results forecasts for the fiscal year ending Oct. 31, due to a reduction in the number of contracts for its stem cell and blood-derived product services.

CellSource's shares dropped nearly 7% in early trade.

According to its Thursday filing, the company now anticipates net sales of 4.37 billion yen from 5.37 billion yen initially and attributable profit of 417 million yen or 21.11 yen per share from 719 million yen or 36.43 yen per share previously, according to its Thursday filing.

Despite an increase in non-operating income from a government subsidy, the decrease in contracts from medical institutions specializing in self-funded treatments has led to a downward revision of earnings.

Price (JPY): $1289.00, Change: $-92, Percent Change: -6.66%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2467750597"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2467750597\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2467750597?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-13 09:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2467750597","market":"hk","top_or_hot":-1,"title":"CellSource Shares Drop 7% After Cutting Fiscal 2024 Financial Forecasts","media":"MT Newswires Live","content":"<html><body><p>CellSource Shares Drop 7% After Cutting Fiscal 2024 Financial Forecasts</p><p> CellSource (TYO:4880) has cut its financial results forecasts for the fiscal year ending Oct. 31,  due to a reduction in the number of contracts for its stem cell and blood-derived product services.</p><p>CellSource's shares dropped nearly 7% in early trade.</p><p>According to its Thursday filing, the company now anticipates net sales of 4.37 billion yen from 5.37 billion yen initially and attributable profit of 417 million yen or 21.11 yen per share from 719 million yen or 36.43 yen per share previously, according to its Thursday filing.</p><p>Despite an increase in non-operating income from a government subsidy, the decrease in contracts from medical institutions specializing in self-funded treatments has led to a downward revision of earnings.</p><p>Price (JPY): $1289.00, Change: $-92, Percent Change: -6.66%</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CellSource Shares Drop 7% After Cutting Fiscal 2024 Financial Forecasts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCellSource Shares Drop 7% After Cutting Fiscal 2024 Financial Forecasts\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MT Newswires Live</strong><span class=\"h-time small\">2024-09-13 09:01</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><p>CellSource Shares Drop 7% After Cutting Fiscal 2024 Financial Forecasts</p><p> CellSource (TYO:4880) has cut its financial results forecasts for the fiscal year ending Oct. 31,  due to a reduction in the number of contracts for its stem cell and blood-derived product services.</p><p>CellSource's shares dropped nearly 7% in early trade.</p><p>According to its Thursday filing, the company now anticipates net sales of 4.37 billion yen from 5.37 billion yen initially and attributable profit of 417 million yen or 21.11 yen per share from 719 million yen or 36.43 yen per share previously, according to its Thursday filing.</p><p>Despite an increase in non-operating income from a government subsidy, the decrease in contracts from medical institutions specializing in self-funded treatments has led to a downward revision of earnings.</p><p>Price (JPY): $1289.00, Change: $-92, Percent Change: -6.66%</p></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.mtnewswires.com/\">MT Newswires Live</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TYO","symbol_name":"3倍沽空7-10年期國債ETF-Direxion","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2467750597","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467750597","pubTimestamp":1726189304,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"CellSource Shares Drop 7% After Cutting Fiscal 2024 Financial Forecasts CellSource (TYO:4880) has cu","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TYO":"3倍做空7-10年期国债ETF-Direxion"},"translate_title":"CellSource下调2024财年财务预测后股价下跌7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TYO":1},"content_text":"CellSource Shares Drop 7% After Cutting Fiscal 2024 Financial Forecasts CellSource (TYO:4880) has cut its financial results forecasts for the fiscal year ending Oct. 31,  due to a reduction in the number of contracts for its stem cell and blood-derived product services.CellSource's shares dropped nearly 7% in early trade.According to its Thursday filing, the company now anticipates net sales of 4.37 billion yen from 5.37 billion yen initially and attributable profit of 417 million yen or 21.11 yen per share from 719 million yen or 36.43 yen per share previously, according to its Thursday filing.Despite an increase in non-operating income from a government subsidy, the decrease in contracts from medical institutions specializing in self-funded treatments has led to a downward revision of earnings.Price (JPY): $1289.00, Change: $-92, Percent Change: -6.66%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}